You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019020
Jan 2020020
Feb 2020010
Mar 2020010
Apr 2020010
May 2020030
Jun 20200120
Jul 2020041
Aug 2020010
Sep 2020063
Oct 2020010
Nov 2020050
Dec 2020020
Jan 2021021
Feb 2021011
Mar 2021010
Apr 2021032
Jun 2021020
Jul 2021020
Aug 2021040
Sep 2021010
Oct 2021051
Nov 2021020
Dec 2021020
Jan 2022030
Feb 2022011
Mar 2022020
Apr 2022021
May 2022041
Jun 2022040
Jul 2022071
Aug 2022051
Sep 2022020
Oct 2022070
Nov 20220103
Dec 2022071
Jan 2023040
Feb 2023010
Mar 2023010
May 2023002
Jun 2023010
Jul 2023012
Aug 2023011
Sep 2023020
Oct 2023011
Nov 2023041
Dec 2023070
Jan 2024090
Feb 2024080
Mar 2024040
Total016425